Can <i>Rhodiola rosea</i> supplementation mitigate digital eye strain? A triple‐blinded placebo‐controlled study
These findings show that RR supplementation (1200 mg/day for 4 days) produced a reduction in the variability of accommodation and one of the assessed DES symptoms, suggesting that it could be considered as a potential strategy to prevent or manage DES. However, further research is needed to determine its clinical relevance and optimise dosage and timing.
Authors
- Pablo Jiménez‐Martínez (ORCID: https://orcid.org/0000-0003-2126-2416)
- Daniel Marcos‐Frutos (ORCID: https://orcid.org/0000-0001-7223-527X)
- Paula M. Lara (ORCID: https://orcid.org/0000-0002-2622-8658)
- Amador García‐Ramos (ORCID: https://orcid.org/0000-0003-0608-8755)
- Carlos Alix‐Fages (ORCID: https://orcid.org/0000-0001-5135-7913)
- Beatríz Redondo (ORCID: https://orcid.org/0000-0003-4571-873X)
- Jesús Vera (ORCID: https://orcid.org/0000-0001-8091-2373)
Institutions
- Universidad de Cantabria (ES)
- Universidad de Granada (ES)
- New England College of Optometry (US)
- Universidad Católica de la Santísima Concepción (CL)
Publication Details
- Journal
- Ophthalmic and Physiological Optics
- Published
- 2025-08-27
- DOI
- https://doi.org/10.1111/opo.70005
- Primary Topic
- Medicinal Plants and Bioactive Compounds
- Type
- article
- Field-Weighted Citation Impact
- 0.00